Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

197 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

MetLife Stock: Is MET Underperforming the Financial Sector?

December 02, 2025 at 07:33 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

With a market cap of $50.3 billion, MetLife, Inc. (MET) is a global financial services company offering insurance, annuities, employee benefits, and asset management solutions. It operates through six major segments, including Group Benefits, Retirement and Income Solutions, and international regions such as Asia and Latin America.

Companies worth more than $10 billion are generally labeled as “large-cap” stocks and MetLife fits this criterion perfectly. The company provides a wide range of products, from life and health insurance to pension risk transfers and capital markets investment offerings.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

The New York-based company's stock has dipped 13.9% from its 52-week high of $88.59. Shares of MetLife have decreased 6.2% over the past three months, a more pronounced decline than the Financial Select Sector SPDR Fund’s (XLF) over 2% drop over the same time frame.

In the longer term, MET stock is down 6.8% on a YTD basis, underperforming XLF’s 9.4% gain. Moreover, shares of the company have fallen 13.5% over the past 52 weeks, outpacing XLF’s over 3% return over the same time frame.

The stock has been trading below its 50-day and 200-day moving averages since mid-October.

MetLife reported strong 3Q 2025 results on Nov. 5, including net income of $818 million and adjusted EPS up 21% to $2.34. The company also delivered robust investment income, solid underwriting performance, and strong sales momentum across key regions like Asia. It further announced $875 million returned to shareholders and $12 billion in new pension risk transfer mandates. However, the stock fell 3.4% the next day.

In comparison, rival Aflac Incorporated (AFL) has outpaced MET stock. Shares of Aflac have gained 5.9% on a YTD basis and dropped 3.9% over the past 52 weeks.

While MET stock has underperformed over the past year, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from 19 analysts' coverage, and the mean price target of $93.38 is a premium of 22.4% to current levels.

On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article